Asana BioSciences, LLC

Release Summary

Asana BioSciences, an oncology focused clinical stage biopharmaceutical company, initiates Phase 2 evaluation of lead molecule ASN002, presenting updated clinical data at ASCO in Chicago June 2-6

Asana BioSciences, LLC